Profile data is unavailable for this security.
About the company
Regen BioPharma Inc. is a biotechnology company. The Company is focused on developing treatments using autologous cell therapies, RNA and DNA-based immunotherapy and small molecules in the immune-oncology and autoimmune disease space. The Company is focused on novel technologies through pre-clinical and Phase I/ II clinical trials. Its primary program consists of identifying small molecules that inhibit or express NR2F6 to immune cell activation for oncology applications and immune cell suppression for autoimmune disease. The Company is also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax, tCellVax, Dura-CAR), modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches (BORIS), and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate).
- Revenue in USD (TTM)236.58k
- Net income in USD-1.27m
- Incorporated2012
- Employees1.00
- LocationRegen BioPharma Inc4700 Spring Street, Suite 304LA MESA 91942United StatesUSA
- Phone+1 (619) 722-5505
- Fax+1 (619) 330-2328
- Websitehttps://regenbiopharmainc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Advance Inc | -100.00bn | -100.00bn | 272.41k | 3.00 | -- | 0.0135 | -- | -- | -- | -- | -- | 0.0212 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0356 | -- | 100.00 | -- | -21.75 | -- | -- | -- |
| Windtree Therapeutics Inc | 0.00 | -48.83m | 306.75k | 14.00 | -- | -- | -- | -- | -8.38 | -8.38 | 0.00 | -0.3449 | 0.00 | -- | -- | 0.00 | -172.27 | -48.72 | -791.65 | -52.57 | -- | -- | -- | -- | -- | -- | 22.36 | -- | -- | -- | 72.96 | -- | -42.51 | -- |
| THC Farmaceuticals Inc | 7.58k | -60.45k | 351.75k | 2.00 | -- | 0.1375 | -- | 46.41 | -0.0036 | -0.0036 | 0.0005 | 0.1411 | -- | -- | -- | 3,790.00 | -- | -- | -- | -- | 100.00 | -- | -1,591.69 | -- | -- | -- | 0.2051 | -- | 348.43 | -- | 5,170.19 | -- | -- | -- |
| Regen BioPharma Inc | 236.58k | -1.27m | 453.14k | 1.00 | -- | -- | -- | 1.92 | -0.0875 | -0.0875 | 0.0088 | -0.1595 | 1.09 | -- | 1.58 | -- | -585.02 | -205.58 | -- | -- | -- | -- | -538.72 | -457.54 | -- | -0.3821 | -- | -- | 0.00 | 16.55 | -90.72 | -- | -- | -- |
| Longevity Health Holdings Inc | 1.46m | -5.74m | 516.88k | 15.00 | -- | -- | -- | 0.3547 | -5.22 | -5.22 | 1.26 | -2.23 | 0.5077 | 1.11 | 47.31 | 97,153.34 | -199.84 | -- | -- | -- | 57.86 | -- | -393.63 | -- | 0.2676 | -- | -- | -- | -- | -- | 36.91 | -- | -- | -- |
| Regenerative Medical Technology Grop Inc | 5.04m | -7.06m | 551.81k | 1.00 | -- | -- | -- | 0.1095 | -0.5629 | -0.5629 | 0.4019 | -2.40 | 1.30 | 24.95 | 69.50 | -- | -182.18 | -177.25 | -- | -- | 59.76 | 64.83 | -140.06 | -465.06 | 0.0784 | -0.0279 | -- | -- | 70.44 | 167.30 | 43.31 | -- | -- | -- |
| Bio Path Holdings Inc | 0.00 | -11.18m | 554.53k | 10.00 | -- | -- | -- | -- | -1.71 | -1.71 | 0.00 | -0.866 | 0.00 | -- | -- | 0.00 | -611.66 | -81.00 | -- | -90.58 | -- | -- | -- | -- | -- | -65.76 | -- | -- | -- | -- | 38.46 | -- | -- | -- |
| Helix BioMedix Inc | 2.07m | -2.58m | 609.46k | 8.00 | -- | 0.3887 | -- | 0.295 | -15.60 | -15.60 | 12.48 | 6.95 | 0.8047 | 1.87 | 4.55 | 258,238.80 | -100.64 | -146.31 | -120.73 | -173.57 | 68.96 | 30.80 | -125.06 | -527.12 | 1.69 | -14.57 | 0.00 | -- | 122.07 | 92.80 | 67.73 | -- | -29.08 | -- |
| Hepion Pharmaceuticals Inc | 0.00 | -9.17m | 662.36k | 22.00 | -- | 0.4065 | -- | -- | -13.39 | -13.39 | 0.00 | 0.2861 | 0.00 | -- | -- | -- | -245.96 | -65.13 | -417.51 | -73.82 | -- | -- | -- | -- | -- | -5.25 | 0.0606 | -- | -- | -- | 73.04 | -- | -- | -- |
